800.676.5565 | [email protected]
View our point of care & Laboratory products
Point of Care Diagnostics
View Products
Laboratory Analyzers and Reagents
View Products
COVID-19/ SARS- CoV-2 Test Options
- Emergency Use Authorized Rapid Test Cassette & Controls
- RT-PCR Lyophilized Multiplex Molecular Tests
- Extraction Instrumentation and Reagents
- Chemiluminescence Immunoassays
- ELISA Systems & Reagents
- Sample Collection and Transportation Media
LOOKING TO INCREASE THE PROFITABILITY OF YOUR LAB?
Jant Pharmacal offers consultation to assist the laboratory professional in maximizing efficiency and profitability.
These services include:
- Financial Feasibility Assessment for Traditional and Toxicology Laboratories
- Turn-Key Laboratory Setup
- CLIA Regulatory and Compliance Consultation
- LCMS Method Development and Installation
- System Specific Method Development and Installation
- Laboratory Information System Selection and Integration
About Jant Pharmacal Corporation
Jant Pharmacal Corporation, founded in 1986, develops and markets medical devices, including complimentary and companion point-of-care diagnostics. The company’s product line offers innovative CLIA-waived rapid tests and diagnostic instrumentation for use in physicians’ offices, clinics, hospitals, and laboratory practice settings. Point-of-care products are marketed under Jant’s registered trademarks: Accutest® and Accustrip®.
ABOUT USLatest NEWS
Rising STI Rates in Summertime
Sexually transmitted infections (STIs) are increasing at an alarming rate worldwide, posing significant public health [...]
12
Jun
Jun
Antibiotic Resistance and the Need for Rapid Detection
Antibiotic resistance is one of the most significant public health threats today. It occurs when [...]
12
May
May
Comprehensive Respiratory Testing for Viral and Bacterial Infections
Respiratory illnesses are surging across the U.S. As of February 21, 2025, the rate of [...]
28
Feb
Feb
COVID-19, Flu, and RSV Continue to Impact Public Health
Respiratory viruses COVID-19, Influenza, and RSV share similar symptoms, making accurate testing essential. With current [...]
10
Feb
Feb
How Genetic Testing Can Help Predict Opioid Use Disorder Risk
AvertD is an FDA-approved genetic test that uses advanced scientific techniques to identify individuals at [...]
13
Nov
Nov
NELC 2024: Don’t Miss Out on the Premier Laboratory Education Innovation Event
With the Northeast Laboratory Conference (NELC) 2024 just around the corner, the excitement is building! [...]
14
Oct
Oct
Jant Pharmacal to Exhibit at Northeast Laboratory Conference 2024
Jant Pharmacal will be exhibiting at the Northeast Laboratory Conference 2024, presenting a range of [...]
04
Oct
Oct
LCMS Testing of Xylazine
Xylazine, an approved animal tranquilizer in the U.S., acts as a sedative and analgesic for veterinary [...]
24
Jul
Jul
